Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine, hydroxychloroquine, or ivermectin for severe COVID-19
RBR-8h7q82Phase 2Completed
- Sponsor
- Universidade Federal de Roraima
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Chloroquine, Hydroxychloroquine and Ivermectin (3 arms). Started May 2020; status: completed.
02
Drugs
chloroquinehydroxychloroquineivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on RBR-8h7q82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8h7q82.